Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
45 Cards in this Set
- Front
- Back
What are 5 antiplatelet drugs?
|
-Aspirin
-Dipyridamole -Ticlopidine -Clopidogrel -Abciximab |
|
What is the major role of platelets in vascular injury?
|
They provide the initial hemostatic plug at the injury site.
|
|
What are 3 pathologic thromotic processes in which platelets participate?
|
-MI
-Stroke -DVT |
|
What causes platelets to adhere to exposed subendothelium of a damaged blood vessel?
|
GP1a/2a - Collagen receptor
GPIb - vWF receptor |
|
What 2 receptors are initially responsible for platelets aggregating?
|
PAR1/PAR4
P2Y1/P2Y12 |
|
What is the ligand for PAR1/PAR4 receptor on platelets?
|
Thrombin
|
|
What is the ligand for P2Y1/P2Y12 receptor on platelets?
|
ADP
|
|
What happens when PAR1/PAR4 and P2Y1/P2Y12 are stimulated?
|
They activate GPIIb/IIIa and Cox-1 to promote platelet aggregation and secretion.
|
|
What is GbIIb/IIIa?
|
Platelet Fibrinogen-binding protein.
|
|
What is the result of GB2b/3a being activated?
|
Fibrinogen binding results in cross-linking of adjacent platelets.
|
|
What is the result of Cox-1 being activated?
|
TxA2 is synthesized which also stimulates platelet aggregation.
|
|
What is the product of Cox-1 in endothelial cells? What is its function?
|
Prostacyclin - inhibits platelet activation to prevent overdoing the platelet aggregation.
|
|
What is the mechanism of Aspirin in preventing platelet aggregation?
|
Irreversible inhibition of platelet cyclooxygenase
|
|
How does aspirin inhibit Cox-1?
|
By acetylating a serine residue near the active site of the enzyme.
|
|
What is not formed as a result of inhibiting cox-1 in platelets?
|
Thromboxane - hence no platelet aggregation.
|
|
How is Aspirin administered?
|
Orally
|
|
What are the 2 adverse effects of Aspirin but what is good about when it's used to prevent platelet aggregation?
|
-Gi upset
-GI bleeding Aspirin doses for this are usually low, so these effects won't be severe. |
|
What are the acute uses of Aspirin?
|
-Acute MI (alone or in combo with a thrombolytic)
-Ischemic stroke -Unstable angina |
|
What are 3 chronic/prophylactic uses of Aspirin?
|
-MI prophylaxis
-Stroke prophylaxis -Preeclampsia prophylaxis |
|
What are 2 actions of Dipyridamole?
|
1. A PDE inhibitor
2. Inhibits the uptake of adenosine by RBCs/EC's |
|
What results from Dipyridamole -inhibiting PDE?
-Inhibiting adenosine uptake? |
-Increased cAMP
-Decreased ADP |
|
And what does increased cAMP and decreased ADP result in?
|
Inhibition of platelet aggregation
|
|
How is Dipyridamole administered?
|
Orally
|
|
What are 3 side effects of Dipyridamole?
|
-Headache
-GI upset -Dizziness |
|
What is the main therapeutic use of Dipyridamole?
|
Prevention of thromboembolism in patients with prosthetic heart valves
|
|
How is Dipyridamole almost always used?
|
With Warfarin
|
|
What are Ticlopidine and Clopidogrel? How do they work?
|
Anti-platelet drugs that act through P2Y1-P2Y12 receptors to inhibig ADP-induced plt aggregation
|
|
What are the Gproteins that are coupled to the P2y1/P2y12 receptors? What effector mechanism results?
|
P2y12 = Gi - decreases adenyl cyclase, decreases cAMP
P2y1 = Gq - increases PLC, increases calcium |
|
What happens when Ticlopidine and Clopidogrel bind the P2y1/P2y12 receptors?
|
They prevent ADP from binding so that it can't induce platelet aggregation.
|
|
What are the 2 clinical manifestations of Blocking ADP induced platelet aggregation with Ticlopidine/Clopidogrel?
|
-Prolonged bleeding time
-Delayed clot retraction |
|
How are Ticlopidine/Clopidogrel administered?
|
Orally as prodrugs that are metabolized to active compounds.
|
|
Which drug is associated with major toxicity?
|
Ticlopidine
|
|
What is the major toxicity associated with Ticlopidine?
|
-Blood dyscrasias
-Neutropenia |
|
What are the 2 main therapeutic indications of Clopidogrel?
|
-MI prophylaxis
-Stroke prophylaxis |
|
What are 6 therapeutic indications of Ticlopidine?
|
-2ndry prevention of cerebrovascular disease
-2ndry prevention of MI -Unstable angina -Coronary artery stenting -Periph vascular disease -TIA's, complicated strokes |
|
What is Abciximab?
|
A GP 2b/3a receptor blocker
|
|
What is GP2b/3a?
|
The plt membrane integrin that binds fibrinogen and is the major plt surface receptor involved in platelet aggregation
|
|
What is Abciximab's mechanism of action?
|
Binds GP2b/3a on platelets and prevents aggregation by preventing binding fibrinogen.
|
|
What 2 types of binding are thought to be involved in the mechanism of action of Abciximab?
|
-Steric hindrance
-Conformational changes block access of fibrinogen to its receptor. |
|
What is NOT likely the mechanism of Abciximab?
|
Not direct interaction with the RGD binding site of GP2b/3a
|
|
How is Abciximab administered?
|
IV as a bolus injection, then continuous infusion for up to 72 hrs
|
|
What are 2 adverse effects of Abciximab?
|
-Bleeding
-Thrombocytopenia is relatively common |
|
What increases the risk of recurrent thrombocytopenia due to Abciximab?
|
Re-exposure to the drug.
|
|
What therapeutic use is Abciximab indicated for?
|
As an adjunct to prevent cardiac ischemia in patients undergoing angioplasty.
|
|
How is Abciximab always given?
|
WITH aspirin and Heparin - only in that setting.
|